Enliven Therapeutics (ELVN) Q4 2025 Earnings

12NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.57
-0.49
-0.4
-0.32

Details

Expected EPS
-0.433333
Actual EPS
-0.32
Surprise EPS
0.11
Surprise Percent
+26.15%

Description

Enliven Therapeutics (ELVN) has reported earnings of -0.32 per share for Q4 2025.

0 Comments

Share your thoughts